Ketorolac Injection Market

It is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.

Ketorolac Injection Market contains market size and forecasts of Ketorolac Injection in global, including the following market information:

Global Ketorolac Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ketorolac Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Ketorolac Injection companies in 2021 (%)

The global Ketorolac Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

15mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ketorolac Injection include Almaject, Amphastar, Fresenius Kabi, Hikma, Pfizer, Sagent, Alvogen, Athenex and BD RX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Ketorolac Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ketorolac Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ketorolac Injection Market Segment Percentages, by Type, 2021 (%)

• 15mg/ml
• 30mg/ml

Global Ketorolac Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ketorolac Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Ketorolac Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ketorolac Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Ketorolac Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Ketorolac Injection revenues share in global market, 2021 (%)
• Key companies Ketorolac Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Ketorolac Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Almaject
• Amphastar
• Fresenius Kabi
• Hikma
• Pfizer
• Sagent
• Alvogen
• Athenex
• BD RX
• Fosun Pharma
• Virtus Pharmaceuticals